보툴리눔톡신(보톡스) 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Global Botulinum Toxin Market size was valued at USD 10.01 billion in 2022 and is poised to grow from USD 11.12 billion in 2023 to USD 23.54 billion by 2031, growing at a CAGR of 9.83% during the forecast period (2024-2031).

The global botulinum toxin (BNT) market is poised for significant growth, driven by increasing demand for cosmetic and non-invasive procedures, alongside advancements in research and development aimed at expanding therapeutic applications beyond its current uses. Comprising seven antigenic forms, notable products include a limited array of BNT-A and a singular BNT-B offering, underscoring the potential for market diversification and innovation. The trend towards new product launches, coupled with improving patient affordability and evolving reimbursement policies that now include coverage for botulinum injections, further propels this growth. With a notable increase in consumer interest in aesthetic treatments, the U.S. market for botulinum toxin is expected to experience a sustainable compound annual growth rate (CAGR) in the forthcoming forecast period. As companies invest strategically in R&D, this will enhance the product portfolio and encourage broader acceptance of botulinum toxin in both cosmetic and therapeutic domains. Overall, the confluence of these factors suggests a promising trajectory ahead for the botulinum toxin market, positioning it as a dynamic segment within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botulinum Toxin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botulinum Toxin Market Segmental Analysis

Global Botulinum Toxin Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Type A (Botox, Dysport, Xeomin, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Cosmetic Centers and Medspas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Botulinum Toxin Market

The increasing demand for minimally invasive cosmetic procedures is a significant market driver for the global botulinum toxin market. As more individuals seek non-surgical options to achieve youthful appearances with minimal recovery time, botulinum toxin treatments have become increasingly popular for reducing wrinkles and fine lines. This trend is further fueled by a growing awareness of the benefits of aesthetic procedures, enhanced by social media influence and celebrity endorsements. Additionally, advancements in technology and product formulations have improved the effectiveness and safety of botulinum toxin therapies, thereby expanding their application in both cosmetic and therapeutic settings, propelling market growth.

Restraints in the Global Botulinum Toxin Market

The global botulinum toxin market may face significant restraints due to the potential side effects associated with its use. Adverse reactions, including muscle weakness, allergic reactions, and localized pain, can deter patients from seeking treatments, thus impacting market growth. Additionally, the perception of safety risks can influence healthcare professionals' recommendations, further complicating patient acceptance. Regulatory scrutiny surrounding the approval and marketing of botulinum toxin products may also pose challenges, as companies must navigate stringent guidelines while addressing concerns related to side effects. The cumulative effect of these factors could inhibit the expansion of the market and limit its overall potential.

Market Trends of the Global Botulinum Toxin Market

The global botulinum toxin market is witnessing significant growth, driven predominantly by cosmetic procedures favored by women, who constitute a remarkable 92% of all treatments. With a rising number of individuals over 40 prioritizing their physical appearance, especially in developed nations, the demand for aesthetics enhancements continues to surge. This trend is emphasized by the remarkable statistic of over 2.5 million women aged 40-54 undergoing botulinum toxin procedures in 2020 alone. As societal norms around beauty evolve, this market trend indicates robust prospects for botulinum toxin, with a sustained focus on anti-aging solutions likely to propel its expansion well into the future.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• PESTEL Analysis
• Technology Analysis
• Regulatory Landscape

Botulinum Toxin Market, By Product

• Market Overview
• Type A
  • Botox
  • Dysport
  • Xeomin
  • Others
• Type B

Botulinum Toxin Market, By Application

• Market Overview
• Therapeutic
  • Chronic Migraine
  • Overactive Bladder
  • Cervical Dystonia
  • Spasticity
  • Others
• Aesthetic
  • Glabellar Lines
  • Crow's Feet
  • Forehead Lines
  • Others

Botulinum Toxin Market, By End User

• Market Overview
• Hospitals
• Dermatology Clinics
• Cosmetic Centers and Medspas

Botulinum Toxin Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Ipsen Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medy-Tox, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metabiologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Supernus Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lanzhou Institute of Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daewoong Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prollenium Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments